Kelsey Goodwin

Stock Analyst

(n/a)
# 2,903
Out of 4,648 analysts
15
Total ratings
n/a
Success rate
n/a
Average return
Main Sectors:
Top Industries:

Stocks Rated by Kelsey Goodwin

Genelux
Oct 29, 2024
Initiates: Buy
Price Target: $8
Current: $3.07
Upside: +160.59%
Nuvalent
Sep 16, 2024
Maintains: Buy
Price Target: $99$105
Current: $89.53
Upside: +17.28%
UroGen Pharma
Aug 22, 2024
Initiates: Buy
Price Target: $40
Current: $11.93
Upside: +235.29%
MacroGenics
Jul 31, 2024
Downgrades: Neutral
Price Target: n/a
Current: $3.70
Upside: -
2seventy bio
Sep 13, 2023
Downgrades: Neutral
Price Target: n/a
Current: $4.51
Upside: -
Arcellx
Jun 20, 2023
Maintains: Buy
Price Target: n/a
Current: $86.44
Upside: -
Legend Biotech
Oct 31, 2022
Initiates: Neutral
Price Target: n/a
Current: $43.61
Upside: -
Iovance Biotherapeutics
Oct 31, 2022
Initiates: Neutral
Price Target: n/a
Current: $11.44
Upside: -
Century Therapeutics
Oct 31, 2022
Initiates: Buy
Price Target: $15
Current: $1.26
Upside: +1,090.48%